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Abstract  (263 words) 
Background: Postoperative infection is a common complication in hip fracture patients and the risk 
appears to have increased during the last decade. However, the impact of infection on mortality 
after hip fracture surgery remains unclear. Purpose: We aimed to examine the association between 
infection (any, as well as specific infections), with all-cause mortality following hip fracture 
surgery. Methods: Using Danish nationwide registries, we conducted a population-based cohort 
study on 74,771 hip fracture patients ≥ 65 years old operated from 2005-2016. We included 
hospital-treated infection as a time-varying exposure, and calculated 30-days mortality rate per 
1000 person-years (PY). We used time-varying Cox Proportional Hazard Regression to compute 
30-days adjusted hazards ratios (aHRs) with 95 % confidence interval (CI) comparing the mortality 
of hip fracture patients with and without infections. We adjusted for sex, age, comorbidities, 
medication use, and marital status. Results: Within 30 days of surgery, 9,592 (12.8%) patients 
developed a hospital-treated infection. Among these, 30-days mortality was 8.43 per 1000 PY 
compared with 3.34 among patients without infection (aHR=2.72, 95 % CI: 2.56-2.88). For patients 
who developed pneumonia, aHR was 4.18 (95 % CI: 3.91-4.48), whereas the aHR was 8.86 (95 % 
CI: 7.88-9.95) for patients who developed systemic sepsis. For patients who sustained reoperation 
due to infection, aHR was 2.95 (95 %CI: 1.88-4.64). The mortality was higher in infected vs. non-
infected patients irrespective of patients’ age, sex and comorbidity. Conclusion: Infection within 30 
days of hip fracture surgery is associated with substantially increased mortality risk. Further 
research should improve our knowledge about patients at increased risk and prevention measures 
for specific infections.   
 




1. Introduction  
Hip fracture is a frequent condition among elderly, and is associated with high morbidity and 
mortality.[1, 2] Approximately 10 % dies within 30 days after surgery, and up to 30 % dies within 1 
year after surgery.[2-4] The high mortality could be attributed to comorbidities already present at 
the time of fracture,[5] but may also be due to postoperative complications.[6, 7] Postoperative 
infection is a common complication in hip fracture patients, and pneumonia is previous reported as 
the most frequent postoperative complication at one hospital in England (9%).[3] The 30-days risk 
of postoperative hospital-treated infection was recently reported to be 14.1 % among Danish hip 
fracture patients, increasing by 32% from 2005-2016.[8]                                                     
Furthermore, postoperative infection has been reported to be among the leading causes of death 
among hip fracture patients.[9] However, the impact of infections on all-cause mortality after hip 
fracture surgery is not clear. Previous research has shown that the 30-days mortality after hip 
fracture surgery is 27-43 % following pneumonia,[3, 10, 11] 21 % following sepsis,[12] and 19 % 
following deep infection.[13] However, to the best of our knowledge, no previous studies have 
evaluated the mortality risk after any infection or used a population-based design. Furthermore, 
neither of the studies considered immortal time bias in their relative risk analysis, which could 
potentially underestimate mortality risk among infected patients [14, 15]. If we classified the 
patients in infected or not-infected group for example within 30 days of follow up, the immortal 
time refers to a period of follow-up during which, by design, death cannot occur, thus, infected 
patients have to survive to be included in infected group Finally, the majority of previous studies 
are from United States and Asia, where the general burden of infections and treatment may differ 
from that in Europe and the Nordic countries.1 
                                                          
Abbrevations: CRS: Civil Registration System, DMHFR: The Danish Multidisciplinary Hip Fracture Registry, DNPR: 
The Danish National Patient Registry, DNHSPD: The Danish National Health Service Prescription Database , PPV: 




Due to the increasing burden of infections and use of antibiotics,[8] as well as risk of developing 
multidrug resistance bacteria,[16] it is highly important to illuminate the impact of infections on the 
mortality after hip fracture surgery. Identification of specific infections and patients who are at 
increased risk of mortality could guide treatment and potentially reduce mortality of hip fracture 
patients.  
We used a large nationwide cohort study to examine the association between infection and all-cause 
mortality following hip fracture surgery. Additionally, we assessed the relationship between 
specific types of infection (pneumonia, systemic sepsis, and reoperation due to infection), and all-
cause mortality. 
2. Methods 
2.1 Setting and design  
We designed a nationwide cohort study, based on prospectively collected patient-level data from 
Danish medical databases. Every Danish citizen (n=5,711,870 in 2016) receives tax-supported 
health care, including free access to hospitals, general practitioners, and outpatient clinics. The 
Danish Civil Registration System (CRS) assigns a unique, personal identifier number used by all 
Danish registries, working as a tool for individual-level linkage between registries.[17] This study is 
based on data linkage between CRS, Danish Multidiciplinary Hip Fracture Registry (DMHFR),[18] 
The Danish National Patient Registry (DNPR),[19] and The Danish National Health Service 
Prescription Database (DNHSPD).[20] 
2.2 Study population  
Using the DMHFR, which is a nationwide clinical-quality database, we identified all patients ≥ 65 
years old with surgically treated medial, pertrochanteric or subtrochanteric femoral hip fracture 




mandatory for every Danish hospital executing hip fracture surgery, and it contains prospectively 
collected pre-, per- and post- operative individual-level data.  
We included patients with a record of either a primary or a secondary hip fracture diagnosis during 
the study period. To be eligible, patients had to have an inpatient hospital admission for their 
fracture and operative treatment including insertion of a primary hip replacement or open reduction 
and internal fixation. Patients identified only on an outpatient basis or in the emergency room were 
not included. 
2.3 Infection       
We obtained information on hospital-treated infections from the DNPR which has registered 
hospital admissions since 1977 and outpatient and emergency visits since 1995.[19] Detailed 
description of DNPR has previously been published.[19] We defined hospital-treated infection as 
any first-time hospital admission or outpatient clinic visit with a primary or secondary infection 
diagnosis at a private or a public hospital, after the hip fracture surgery date. Additionally, we 
divided any infection into specific groups of infections, including pneumonia, systemic sepsis, and 
reoperation due to infection. We further explored the risk of urinary track infection. In order to 
avoid immortal time bias, we defined infection as time-varying exposure.[14, 15] Thus, the patients 
were classified as unexposed from the date of surgery up until the exact day of infection, and then 
classified as exposed throughout the rest of the follow-up period. Hence, the index date for all 
patients was defined as the date of hip fracture surgery, whereas infected patients contributed to the 
unexposed group initially (from hip fracture surgery) but were then moved to the exposed group 
from the day of infection, which became their index date (See Supplementary Figure 1). Patients 
with a hospital-treated infection between 0-30 days after index date were eligible in our analysis. 




infection (because they cannot die if they will develop an infection later on), and in reality still 
unexposed, because they not have developed an infection yet. [14, 15] If we instead followed every 
patient from the date of surgery and defined exposure as infection within 30 days (binary; yes or 
no), this would lead to misclassified immortal time. Hence, the exposed group would include 
immortal person-time that instead belonged to the unexposed group, potentially leading to bias 
downwards. 
2.4 Mortality  
The study outcome was all-cause mortality, obtained from the Danish CRS. The CRS was 
established in 1968 and contains electronic records on vital status (date of death or emigration) for 
the entire Danish population and is updated daily.[17] We examined short-term mortality, defined 
as the risk of dying 0-30 days after the index date. We focused on 30-days mortality in order to 
stress postoperative and hip fracture related infection. 
2.5 Covariates  
Patient characteristics, including sex, age (65-74, 75-84, and ≥85), fracture type (femoral neck, and 
per/subtrochanter fracture), operation type (total/hemi arthroplasty, and osteosynthesis), surgery 
delay (<24, 24-36, >36 hours, and unknown), operation year (2005-2006, 2007-2008, 2009-2010, 
2011-2012, 2013-2014, and 2015-2016) and body mass index [BMI; weight in kilograms (kg) 
divided by the square of height in meters (m) (<18.5 kg/m2, 18.5- 24.9 kg/m2, 25-29.9 kg/m2, and 
≥30 kg/m2)], were collected from DNHSPD at index date.   
We obtained information on comorbidity from DNPR ten years prior to index date, and detected 19 
major comorbidities included in Charlson Comorbidity Index (CCI) score.[21] We classified 




CCI (score 1-2), and high CCI (score 3 or more). Presence of one or more alcohol-related 
comorbidities (not included in CCI) was included separately.                                                                   
From the DNHSP, we collected data on medication: systemic corticosteroids, antibiotic use, oral 
anticoagulants, anti-osteoporotic medication, statins, non- steroidal anti-inflammatory drugs 
(NSAIDs), and selective serotonin reuptake Inhibitors (SSRIs). The DNHSP contains data on all 
dispensings from community pharmacies and hospital-based outpatient pharmacies in Denmark 
since 2004, coded according to the Anatomical Therapeutic Chemical classification system.[20] 
Current medication use was classified as at least one dispensing prescription within 90 days prior 
index date, and former medication use as prescription within 91-365 days prior index date. Marital 
status (married/unmarried) was included as a covariate of social conditions and detected from CRS 
(All codes for the study variables are available in Supplementary Table 1).  
2.6 Statistical analysis  
We tabulated characteristics of the study population by infection status within 30 days after surgery 
(binary; yes or no). We followed patients from index date and up until death or end of follow-up (30 
days after surgery date) in order to assess infection status as time-varying exposure and 
subsequently calculated 30-days mortality rates (MRs) for each group, as the numbers of deaths 
divided by the total of risk-time, expressed by 1,000 person-years. To evaluate the association 
between infection and mortality, we used time-varying Cox Proportional Hazard Regression to 
compute crude and multivariable-adjusted hazards ratios (HRs) with 95 % confidence interval (CI). 
In our multivariable analysis, we adjusted for sex, age, CCI-score, alcohol-related comorbidities, 
current medication use (systemic corticosteroids, SSRI, oral anticoagulants, and antibiotics), and 
marital status. Furthermore, we stratified according to sex, age and CCI-score, while adjusting for 




analyzed by log-minus-log plot, and accepted. Additionally, we performed a sensitivity analysis to 
examine potential residual confounding of comorbidity. We repeated the analysis adjusting for 
specific comorbidities (diabetes, dementia, moderate to severe kidney disease, liver disease, chronic 
pulmonary disease, congenital heart disease, any tumor and metastatic tumor) instead of using CCI-
score.  
All statistical analyses were conducted using Stata Version 15.0 (Stata Corp, College Station, 
Texas, USA). 
2.7 Ethical consideration  
The study has been approved by the Danish Data Protection Agency (Jr.nr at Region of Central 
Denmark 1-16-02-467-15). Registry based studies do not require formal ethical approval according 
to Danish law.  
3. Results  
3.1 Description of the study population 
Among 74,771 hip fracture patients, 9,592 (12.8%) sustained infection within 30 days after surgery. 
Infected patients had higher levels of comorbidity, were more likely to use medication like SSRI, 
antibiotics, and oral anticoagulants’ shortly before surgery, and were more often males, compared to 
non-infected patients (Table 1).  Median age at the time of operation was 84 years in infected 
patients and 82 years in non-infected patients.  
Figure 1A shows distribution of postoperative days when infection was diagnosed. The most 
frequent day of postoperative infection was day 1 after surgery, and median time to infection 
diagnosis was postoperative day 8. The exact day of death after postoperative infection is presented 
in Figure 1B. The median time to death after developing a postoperative infection was 6 days, but 




infections (Table 2) represent 95 % of any infection. The remaining 5 % infections includes various 
gastrointestinal infections, skin infections, abscess etc (See Supplemental Table 1 for a complete list 






























Baseline characteristics of hip fracture cohort 
                                                                                                                                                         
                                            
Patient characteristics  
 
Patients with infection 
 





    
No. of patients 9,592 65,179 74,771 
    
Gender     
Female  6,387 (67%) 46,959 (72%) 53,346 (71%) 
Male  3,205 (33%) 18,220 (28%) 21,425 (29%) 
    
Age, years     
Median age  84 82 83 
65-74 1,438 (15 %) 12,964 (20%) 14,402 (19 %) 
75-84 3,639 (38%) 25,102 (38%) 28,741 (38%) 
≥85 4,515 (47%) 27,113 (42%) 31,628 (42%) 
    
Charlson Comorbidity 
Index score 
   
- 0 (No comorbidity) 3,133 (32%) 26,986 (41%) 30,099 (40%) 
- 1-2 (Medium) 4,102 (43%) 26,143 (40%) 30,245 (40%) 
- 3+ (High) 2,377 (25%) 12,050 (18%) 14,427 (19%) 
    
Alcohol-related conditions*    
None 9,183 (96%) 62,951 (97%) 72,134 (96 %) 
1 or more 409 (4%) 2,228 (3 %) 2,637 (4%) 
    
Fracture type    
Fracture of femoral neck 4,817 (50%) 34,781 (53 %) 39,598 (53 %) 
Per and Sub-trochanter 
fractures 
4,775 (50%) 30,398 (47 %) 35,173 (47 %) 
    
Operation type    
Osteosyntheses 6,556 (68) 44,980 (69%) 51,536 (69%) 
Total and hemi hip arthroplasty 3,036 (32) 20,199 (31%) 23,235 (31%) 
    
Married status     
Unmarried  6,917 (72%) 45,760 (70%) 52,677 (70%) 
Married  2,675 (28%) 19,419 (30%) 22,094 (30%) 
    
Medication use    
Anti-Osteoporotic medication 
-Former use 












-Former use  




































Table 1: Baseline characteristics of the hip fracture cohort patients, with or without 
infection 30 days after surgery, Denmark, 2005-2016 
-Current use  
 
1,826 (19%) 11,714 (18%) 13,540 (18%) 
NSAID 
-Former use  












-Former use  











Oral Antikoagulantia  
-Former use  












-Former use  
-Current use  
 
2,415 (25%) 
2,623 (27 %) 
 
15,589 (24%) 
14,904 (23 %) 
 
18,004 (24 %) 
17,527 (23 %) 
    
Operation year     
2005-2006 1,339 (14%) 11,114 (17%) 12,453 (17%) 
2007-2008 1,482 (15%) 11,754 (18%) 13,236 (18%) 
2009-2010 1,679 (17%) 11,045 (17%) 12,724 (17%) 
2011-2012 1,690 (18%) 11,016 (17%) 12,706 (17%) 
2013-2014 1,771 (19%) 10,514 (16%) 12,285 (16%) 
2015-2016  1,631 (17%) 9,736 (15%) 11,367 (15%) 
    
Body Mass Index, kg/m2    
Underweight  <18.5 903 (9%) 5,551 (9%) 6,454 (9%) 
Normal weight 18.5- 24.9 4,244 (44%) 29,737 (46%) 33,981 (45%) 
Overweight 25-29.9 1,782 (19%) 12,906 (20%) 14,688 (20%) 
Obese ≥30 565 (6%) 3,538 (5%) 4,103 (5%) 
Unknown 2,098 (22%) 13,447 (21%) 15,545 (21%) 
    
Specific comorbidities (yes)    
Peripheral vascular disease 926 (10%) 60,186 (92%) 5,919 (8%) 
Cerebrovascular disease 2,055 (21%) 11,720 (18%) 13,775 (18%) 
Chronic pulmonary disease 1,798 (19%) 7,530 (12%) 9,328 (12%) 
Diabetes type 1 and 2 1,016 (11%) 5,378 (8%) 6,394 (9%) 























Figure 1A and 1B: 
1A: Frequency of postoperative infection within 30 days,                                 1B: Numbers of deaths within infected patients,                                         




3.2 Mortality in infected vs. non-infected patients 
A total of 1,443 of 9,592 (15%) infected patients died within 30 days of hip fracture surgery. 
Patients who sustained any infection within 30 days of hip fracture surgery were more likely to die 
during the follow-up period of 30 days than those with absence of infection. Unadjusted mortality 
rates (MR) were 8.43 (95 % CI: 8.00-8.88) by 1,000 person-years for infected patient, and 3.34 (95 
% CI: 3.26-3.43) for non-infected patients, corresponding to an aHR of 2.72 (95 % CI: 2.56-2.88) 
(Table 2). The 30-days mortality risk was over 4-fold higher for patients who sustained pneumonia 
compared to non-pneumonia patients [aHR: 4.18 (95 % CI: 3.91-4.48)]. Patients with systemic 
sepsis were associated with the highest risk of 30-days mortality in our study, corresponding to aHR 
of 8.86 (95 % CI: 7.88-9.95) compared to non-systemic sepsis patients. The aHR for patients who 
underwent reoperation due to infection was 2.95 (95 % CI: 1.88-4.64) compared to patients without 
reoperation due to infection. In contrast, sustaining UTIs was associated with lower mortality risk 
[aHR: 0.69 (95 % CI: 0.60-.0.79)]. Table 2 shows numbers of infections and MRs for sepsis, 
pneumonia, UTIs and reoperation due to infection.  
The sensitivity analysis adjusting for specific comorbidities instead of  CCI-score did not 






Table 2: Mortality risk and Hazard Ratio (HR) following infection* within 30 days 
after hip fracture surgery 
 
* Infection was treated as time-varying exposure. **Person-Years (PY) *** Hazard ratios were adjusted for sex, age, 













30 days after 
surgery  
 
  No. Of        No. Of         PY**          Mortality Rate pr.                Crude HR              Adjusted HR   




















9,592         1,443 
74,771        6.451 
 
 
 3,938           969 
74,771        6,925 
 
 
  761            300· 




  261             19· 













































































 4,328          213 




























3.3 Stratified analyses 
The 30 days mortality risk was highly increased for any infection, systemic sepsis, pneumonia, and 
reoperation due to infection irrespective of sex, age, and CCI-score (Figure 2, 3, 4, and 
Supplementary Figure 2). Age ≥ 85, high comorbidity and males, had the highest MR among the 
infected patients. However, the aHR was 2-4 times higher for any infected patients in all groups. 
For pneumonia, aHR was 5.30 (95 % CI: 4.63-6.07) among patients with no comorbidities, and 3.40 
(95 % CI: 3.00-3.87) among patients with high comorbidity level. Systemic sepsis was associated 
with an aHR of 12.75 (95 % CI: 10.05-16.17) among patients with no comorbidities, and 7.32 (95 
% CI: 5.97-8.96) among patients with high comorbidity level. In addition, we observed gender 
differences in the association between mortality and systemic sepsis, where females had an aHR 
mortality of 13.14 (95 % CI: 11.21-15.40), and males had an aHR of 6.63 (95 % CI: 5.58-7.87), 






                                                          Mortality Ratea                       Adjusted HRb 
                                         With infection           Without infection    









Figure 2: Association between any infection* and mortality 0-30 days after hip fracture, stratified by sex, Charlson 
Comorbidity Index-score and age, Denmark 2005-2016 
 
* Infection was treated as time-varying exposure. a: Per 1000 person-years (with corresponding 95 % CI) b: Hazard ratios were adjusted for sex, age, 
and comorbidity level, without the stratifying variable (with corresponding 95 % CI) 
 
 
Female  6.46 (6.02-6.94) 2.74 (2.66-2.83) 2.60 (2.40-2.82) 
Male 12.82 (11.89-13.82) 4.94 (4.75-5.13) 3.03 (2.78-3.31) 
    
CCI Low 6.30 (5.69-6.99) 2.26 (2.16-2.37) 2.90 (2.58-3.25) 
CCI Medium 8.77 (8.11-9.47) 3.54 (3.41-3.68) 2.91 (2.66-3.18) 
CCI High  10.85 (9.88-11.91) 5.41 (5.17-5.66) 2.51 (2.25-2.78) 
    
Age 65-74 4.98 (4.20-5.90) 1.33 (1.22-1.45) 4.07 (3.34-4.97) 
Age 75-84 7.26 (6.64-7.94) 2.37 (2.26-2.48) 3.50 (3.15-3.88) 
Age ≥ 85 10.56 (9.86-11.30) 5.30 (5.14-5.46) 2.35 (2.18-2.54) 






                                                            Mortality Ratea                    Adjusted HRb 
                                          With pneumonia       Without pneumonia    









Figure 3: Association between pneumonia* and mortality 0-30 days after hip fracture surgery, stratified by sex, 
Charlson Comorbidity Index-score and age, Denmark 2005-2016 
 
* Pneumonia was treated as time-varying exposure. a: Per 1000 person-years (with corresponding 95 % CI) b: Hazard ratios were adjusted for sex, age, 
and comorbidity level, without the stratifying variable (with corresponding 95 % CI) 
 
 
Female  12.19 (11.12-13.35) 2.80 (2.71-2.88) 4.61 (4.18-5.09) 
Male 18.48 (16.94-20.16) 5.02 (4.84-5.21) 4.09 (3.71-4.51) 
    
CCI Low 13.30 (11.74-15.06) 2.29 (2.19-2.40) 5.30 (4.63-6.07) 
CCI Medium 15.06 (13.72-16.54) 3.60 (3.47-3.73) 4.54 (4.10-5.03) 
CCI High  16.07 (14.29-18.06) 5.50 (5.27-5.74) 3.40 (3.00-3.87) 
    
Age 65-74 8.70 (7.07-10.69) 1.38 (1.27-1.50)  5.82 (4.63-7.32) 
Age 75-84 13.03 (11.69-14.52) 2.44 (2.33-2.55) 5.30 (4.70-5.98) 
Age ≥ 85 18.47 (16.99-20.08) 5.33 (5.17-5.49) 3.69 (3.37-4.05) 







                                                  Mortality Ratea                          Adjusted HRb 
                                       With sepsis             Without sepsis  









Figure 4: Association between systemic sepsis* and mortality 0-30 days after hip fracture surgery, stratified by sex, 
Charlson Comorbidity Index-score CI-score and age, Denmark 2005-2016  
 
* Systemic sepsis was treated as time-varying exposure. a: Per 1000 person-years (with corresponding 95 % CI) b: Hazard ratios were adjusted for sex, 
age, and comorbidity level, without the stratifying variable (with corresponding 95 % CI) 
 
Female  35.71 (30.60-41.68) 2.93 (2.85-3.02) 13.14 (11.21-15.40) 
Male 30.59 (25.90-36.12) 5.46 (5.27-5.66) 6.63 (5.58-7.87) 
    
CCI Low 34.42 (27.32-43.36) 2.45 (2.35-2.56) 12.75 (10.05-16.17)  
CCI Med. 32.09 (27.00-38.13) 3.86 (3.73-3.99) 8.82 (7.38-10.54) 
CCI High  33.67 (27.65-41.01) 5.76 (5.53-6-01) 7.32 (5.97-8.96) 
    
Age 65-74 22.94 (16.82-31.27) 1.48 (1.36-1.60) 12.25 (8.85-16.96) 
Age 75-84 29.10 (24.18-35.02) 2.64 (2.53-2.75) 10.06 (8.30-12.20) 
Age ≥ 85 42.79 (36.42-50.27) 5.63 (5.48-6.00) 7.61 (6.44-8.98) 




4. Discussion  
This population-based cohort study indicates excessive risk of 30-days mortality among hip fracture 
patients following any postoperative infection, in particularly after systemic sepsis, pneumonia, and 
reoperation due to infection. The mortality was increased regardless of patients’ age, sex, and 
comorbidity.                                                                                                                                           . 
To the best of our knowledge, this is the largest conducted study demonstrating the association 
between infection and mortality after hip fracture surgery. We extended existing knowledge 
evaluating the mortality following any postoperative infection, instead of just specific types of 
infections. We provided further evidence on increased mortality after infection by stratifying on 
age, sex, and comorbidity.  
Our study supports previous findings of elevated mortality after pneumonia, sepsis, and surgical site 
infection within 30 days after hip fracture surgery.[3, 10-13] However, both Roche et al.,[3] and Lv 
et al.,[11] found approximately 3 times higher mortality after postoperative pneumonia (resulting in 
a 30-days mortality of 27-43 %), whereas we demonstrated over 4 times higher mortality risk. 
Moreover, we found a higher mortality following sepsis compared to those reported from Bohl. et 
al.[adjusted RR: 4.4 (95 % CI: 3.7-5.4)].[12] This disparity might potentially be explained by 
immortal time bias in previous studies, as we were the only study using time-varying exposure in 
order to avoid a potential underestimation of the association. However, changes could also be 
related to differences in exposure time and it’s definition, different use of adjusted variables, or the 
differences in characteristics of the study populations and sample size.        
Male, high age, and comorbidities are associated with higher mortality following hip fracture 
surgery in general,[2, 3, 5] corresponding to our mortality rates among infected patients as well. 
However, we observed that the relative mortality increased irrespective of age, sex, and 




comorbidities, and at lowest age. Thus, our findings suggest that infections not only increase 
mortality among the most vulnerable patients, but also have an even larger impact on the most 
“healthy” patients. This is probably due to a higher mortality rate among older and more comorbid 
patient in general, so sustaining an infection has less influence compared to the younger and more 
“healthy” patients. 
Furthermore, we found a much higher mortality after systemic sepsis among females compared to 
males, resulting in a slightly higher mortality rate among females compared to males following 
systemic sepsis. This might suggest that sepsis could contribute to a gender difference within 30-
days mortality. Wehren et al.,[22] has previous suggested that infection could play part as one of the 
explanation of the gender differences in 1-year mortality. However, the underlying mechanisms 
regarding this are not fully understood.  
In contrast to other infections, we found a reduced mortality following UTIs after hip fracture 
surgery. Interestingly, Roche et al. also demonstrated reduced 30-days mortality after UTIs [aHR: 
0.6 (95 % CI: 0.3-1.4)][3]. Our results regarding UTI should be interpreted with caution. UTI 
diagnosis is in particular risk for being underreported because the diagnosis does not provide 
reimbursement for department. Thus, our results could be due to chance alone. It is further likely 
that many patients already have UTI before being hospitalized for hip fracture, and detection and 
treatment for UTI during hospitalization and afterword would increase prognosis of patients. 
4.1 Methodological considerations 
The major strengths of this study is based on the population-based design, including the large 
sample size and prospective collected individual-level data from medical databases. We detected 
hip fracture surgery from DMHFR, which has mandatory registration and a measured completeness 




high.[23] Furthermore, we have almost complete follow-up, with low risk of selection bias. We 
adjusted for many different confounders, including medication use. We used CCI, a highly 
implemented index score,[21] in order to control for comorbidity. The positive predictive value 
(PPV) of the comorbidity codes from DNPR has consistently very high accuracy.[24] In addition, 
we collected information on infections based on ICD-10 codes in the DNPR, and a high accuracy of 
these codes is previous indicated (the PPV of any infection diagnosis was 98 % among cancer 
patients during 2006-2010).[25] Finally, our study avoids potential immortal bias by using novel 
method of time-varying exposure (See Supplementary Figure 1). To our knowledge, this is the first 
study to evaluate the association between mortality and infection after hip fracture surgery fully 
without a potential immortal bias. 
However, our study includes some limitations. We were not able to adjust for socioeconomic status 
or life style factors. Anyhow, we adjusted for alcohol-related comorbidities, comorbidities related to 
smoking (Chronic Obstructive Pulmonal Disease (COPD)), and marital status to diminish the 
potential bias. In addition, we adjusted for all the 19 comorbidities included in CCI regardless of 
type of infection, and did not take into account that some comorbidities could be more important 
than others for some specific infections (for example COPD and pneumonia). Furthermore, we did 
not have any information on psychiatric comorbidities or comorbidities treated by general 
practitioners (GPs), and our study could be affected by residual confounding. Our results regarding 
sepsis and reoperation due to infection has lower power, especially in the stratified analysis. An 
additional limitation comprehend that the sensitivity of infection codes in DNPR is unknown, and 
infections are probably underreported. Even so, since the mortality outcome is unknown at the time 
of the infection registration, the potential misclassification is most likely non-differentiated, and 




4.2 Possible explanations and clinical perspectives                                                                                   
There are mainly multiple factors contributing to high mortality after postoperative infection among 
hip fracture patients. These patients have high age, and are presented with multimorbidity and 
polypharmacy. Age-related changes involves a dysregulation in the immune system, known as 
immunosenescence.[26] In addition, infections in elderly might be overlooked. Even with a severe 
infection, typical symptoms like fever, might not be presence in elderly.[27, 28] The lack of 
symptoms may lead to delayed diagnosis and therapy, potentially contributing to increased 
mortality among the infected patients.[27, 29]                                                                                                            
…… Our findings suggest that preventing any infection would be beneficial in order to reduce the 
30-days mortality after hip fracture surgery. Early remobilization, respiratory exercises, and 
nutritional support could potentially avert some types of postoperative infections.[30, 31] Systemic 
prophylactic antibiotics in hip fracture surgery is well-recommended,[32, 33] but doses, durations, 
and combinations might be optimized. Furthermore, the rehabilitation of the patients immediately 
after discharge, including resources in municipalities, as well as collaboration with GPs, is 
presumably highly important for the prognosis following postoperative infections.       
In conclusion, this population-based study provides evidence of substantially increased 30-days 
mortality risk following any postoperative infection, after hip fracture surgery. The risk increased 
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